By David Moore, Professor of Infectious Diseases and Tropical Medicine at the London School of Hygiene & Tropical Medicine
“It is quite possible that we will see a drug-resistant tuberculosis epidemic of unprecedented global scale.” The view of Dr David W Dowdy from Johns Hopkins Bloomberg School of Public Health in a Lancet Respiratory Medicine comment piece this week. Alarming words, and we need to listen.
By Ngozi Erondu, London School of Hygiene & Tropical Medicine
In his latest annual letter, Bill Gates warned of the imminent threat of a deadly pandemic to the global community. Yet, while his message also lauds the accomplishments of vaccine coverage, he has consistently lacked the emphasis on a crucial element of global health security: If we truly want to prepare for the next pandemic we need to invest in health systems, not just vaccine development.
By Peter Piot, Director of the London School of Hygiene & Tropical Medicine
Throughout my career I have been at the frontline in the fight against some of the toughest health emergencies of our times. In the 1970s I was working to quell the outbreak of the then-unknown Ebola virus. In the 1990s I was leading the newly-created UNAIDS to tackle one of the greatest pandemics of modern times – the HIV/AIDS epidemic.
By Benjamin Hawkins, London School of Hygiene & Tropical Medicine and Ross MacKenzie, Macquarie University.
The evidence that e-cigarettes help people quit smoking was described in the World Health Organisation’s (WHO) recent report as “scant and of low certainty”. Predictably, this triggered the latest round of claims and counterclaims in an ongoing, and often acrimonious, dispute about the potential of e-cigarettes.
By Stefan Flasche, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine
'Dengue fever kills 20 in Burkina Faso’ reports the BBC. ‘Dengue claims 26 lives in Maharashtra’ leads the Times of India. Deaths from dengue are actually rare but these recent headlines are a reminder of the dangers the virus poses and the need for a concerted global effort to tackle it. Read more
By Hannah Kuper, Co-director of International Centre for Evidence in Disability, London School of Hygiene & Tropical Medicine
I recently sat with a mother and her baby in an intensive care unit in Rio de Janeiro, Brazil. The baby was tiny, with lots of dark hair and a beautiful name. He also had microcephaly – and the doctor euphemistically said that his face was disproportionate to his head.
By Rein Houben, London School of Hygiene & Tropical Medicine, and Pete Dodd, University of Sheffield.
In rich countries, tuberculosis is sometimes thought of as a thing of the past, the disease that claimed Keats, Poe, Chopin. But globally, TB is today the number one infectious killer, causing an estimated 1.8m deaths in 2015. Read more
By Meenakshi Gautham, Research Fellow - IDEAS Country Coordinator, and Timothy Powell-Jackson, Associate Professor in Health Economics at the London School of Hygiene & Tropical Medicine.
India faces a ticking-time bomb when it comes to public health. In 2015 it reported 27% of all neonatal deaths and 21% of all child deaths in the world, and the country accounted for 20% of the global burden of disease in 2013. More than 70% of ailing persons sought care in the private health sector in 2014 and it is well known that a large proportion of this private sector is informal and unrecognised.
By Rebecca Tremain.
We are pleased to announce the recipients of the second year of funding for the Small Grants Scheme for Public Engagement. Read more
By Sandra Mounier-Jack, Senior Lecturer in Health Policy at the London School of Hygiene & Tropical Medicine.
In April 2013, the National Health Service (NHS) in England was subject to the biggest reorganisation since its creation in 1948. NHS leaders famously described the changes as “so big you could see them from space”.
In a very short space of time, new organisations were created, old ones abolished and responsibilities for public health were transferred from the NHS to local authorities. In the midst of these changes, we investigated what happened to the national immunisation programme.